Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial.

Journal article

EMPA-KIDNEY Collaborative Group None., (2022), Nephrol Dial Transplant, 37, 1317 - 1329

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.

Journal article

Task Force for the management of COVID-19 of the European Society of Cardiology None. et al, (2022), Cardiovascular research, 118, 1385 - 1412

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

Journal article

HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up.

Journal article

Task Force for the management of COVID-19 of the European Society of Cardiology None., (2022), European heart journal, 43, 1059 - 1103

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.

Journal article

Task Force for the management of COVID-19 of the European Society of Cardiology None., (2022), European heart journal, 43, 1033 - 1058

CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA

Presentation

Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16

A model of lifetime health outcomes in cardiovascular disease based on clinical trials and large cohorts

Presentation

Wu R. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3149 - 3149

Pragmatic Trials - Need for ADAPTABLE Design.

Journal article

Baigent C., (2021), N Engl J Med, 384, 2065 - 2066

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.

Journal article

Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570

Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.

Journal article

Copland E. et al, (2021), Lancet Oncol, 22, 558 - 570

2020 ESC Guidelines for the management of adult congenital heart disease.

Journal article

Baumgartner H. et al, (2021), Eur Heart J, 42, 563 - 645

Load More